Literature DB >> 18384644

Retrograde axonal transport and motor neuron disease.

Anna-Lena Ström1, Jozsef Gal, Ping Shi, Edward J Kasarskis, Lawrence J Hayward, Haining Zhu.   

Abstract

Transport of material between extensive neuronal processes and the cell body is crucial for neuronal function and survival. Growing evidence shows that deficits in axonal transport contribute to the pathogenesis of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Here we review recent data indicating that defects in dynein-mediated retrograde axonal transport are involved in ALS etiology. We discuss how mutant copper-zinc superoxide dismutase (SOD1) and an aberrant interaction between mutant SOD1 and dynein could perturb retrograde transport of neurotrophic factors and mitochondria. A possible contribution of axonal transport to the aggregation and degradation processes of mutant SOD1 is also reviewed. We further consider how the interference with axonal transport and protein turnover by mutant SOD1 could influence the function and viability of motor neurons in ALS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384644      PMCID: PMC4477783          DOI: 10.1111/j.1471-4159.2008.05393.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  88 in total

Review 1.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Fast axonal transport in amyotrophic lateral sclerosis: an intra-axonal organelle traffic analysis.

Authors:  A C Breuer; M P Lynn; M B Atkinson; S M Chou; A J Wilbourn; K E Marks; J E Culver; E J Fleegler
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

Review 3.  Current status of SOD1 mutations in familial amyotrophic lateral sclerosis.

Authors:  M Gaudette; M Hirano; T Siddique
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

4.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1(G93A G1H) mouse model of familial amyotrophic lateral sclerosis.

Authors:  Michael F Azari; Elizabeth C Lopes; Chantelle Stubna; Bradley J Turner; Dawei Zang; Nicos A Nicola; John B Kurek; Surindar S Cheema
Journal:  Brain Res       Date:  2003-08-22       Impact factor: 3.252

6.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

7.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

8.  Coordination of opposite-polarity microtubule motors.

Authors:  Steven P Gross; Michael A Welte; Steven M Block; Eric F Wieschaus
Journal:  J Cell Biol       Date:  2002-02-28       Impact factor: 10.539

9.  Mechanism of dynamitin-mediated disruption of dynactin.

Authors:  Karin A Melkonian; Kerstin C Maier; Jamie E Godfrey; Michael Rodgers; Trina A Schroer
Journal:  J Biol Chem       Date:  2007-04-22       Impact factor: 5.157

10.  Genetic analysis of the cytoplasmic dynein subunit families.

Authors:  K Kevin Pfister; Paresh R Shah; Holger Hummerich; Andreas Russ; James Cotton; Azlina Ahmad Annuar; Stephen M King; Elizabeth M C Fisher
Journal:  PLoS Genet       Date:  2006-01       Impact factor: 5.917

View more
  32 in total

1.  A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction.

Authors:  Xiaohu Tang; Kathleen I Seyb; Mickey Huang; Eli R Schuman; Ping Shi; Haining Zhu; Marcie A Glicksman
Journal:  J Biomol Screen       Date:  2011-12-01

2.  Cargo distributions differentiate pathological axonal transport impairments.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2012-01-25       Impact factor: 2.691

Review 3.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

4.  A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop.

Authors:  Kathleen S Molnar; N Murat Karabacak; Joshua L Johnson; Qi Wang; Ashutosh Tiwari; Lawrence J Hayward; Stephen J Coales; Yoshitomo Hamuro; Jeffrey N Agar
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

Review 5.  Mitochondrial dysfunction in amyotrophic lateral sclerosis.

Authors:  Ping Shi; Jozsef Gal; David M Kwinter; Xiaoyan Liu; Haining Zhu
Journal:  Biochim Biophys Acta       Date:  2009-08-26

6.  Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.

Authors:  Anna-Lena Ström; Ping Shi; Fujian Zhang; Jozsef Gal; Renee Kilty; Lawrence J Hayward; Haining Zhu
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

7.  Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy.

Authors:  Ortal Barel; May Christine V Malicdan; Bruria Ben-Zeev; Judith Kandel; Hadass Pri-Chen; Joshi Stephen; Inês G Castro; Jeremy Metz; Osama Atawa; Sharon Moshkovitz; Esther Ganelin; Iris Barshack; Sylvie Polak-Charcon; Dvora Nass; Dina Marek-Yagel; Ninette Amariglio; Nechama Shalva; Thierry Vilboux; Carlos Ferreira; Ben Pode-Shakked; Gali Heimer; Chen Hoffmann; Tal Yardeni; Andreea Nissenkorn; Camila Avivi; Eran Eyal; Nitzan Kol; Efrat Glick Saar; Douglas C Wallace; William A Gahl; Gideon Rechavi; Michael Schrader; David M Eckmann; Yair Anikster
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

8.  Neuropeptide delivery to synapses by long-range vesicle circulation and sporadic capture.

Authors:  Man Yan Wong; Chaoming Zhou; Dinara Shakiryanova; Thomas E Lloyd; David L Deitcher; Edwin S Levitan
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

9.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

10.  Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

Authors:  Isaac M Chiu; Hemali Phatnani; Michael Kuligowski; Juan C Tapia; Monica A Carrasco; Ming Zhang; Tom Maniatis; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.